Chiglitazar Added to Metformin for Type 2 Diabetes

Clinical trial NCT04807348 · COMPLETED

Trial details

NCT number: NCT04807348
Sponsor: Chipscreen Biosciences, Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2021-07-06
Primary completion: 2023-02-10
Enrollment: 533

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.